.

Chemplast Sanmar Q4 and FY26: A Strong Quarter, but the Commodity Cycle Still Hurts

Chemplast Sanmar closed Q4 FY26 with a sharp recovery in operating performance. Consolidated revenue rose to INR 1,256 crore in Q4 FY26 from INR 835 crore in Q3 FY26 and INR 1,151 crore in Q4 FY25. EBITDA improved to INR 194 crore in Q4 FY26 versus INR 37 crore a year ago, and versus negative INR 57 crore in Q3 FY26. Despite this, the quarter still ended with a consolidated loss of INR 45 crore.

For the full year, the picture remained challenging. Consolidated revenue slipped to INR 4,224 crore in FY26 from INR 4,346 crore in FY25, while EBITDA was INR 198 crore versus INR 219 crore. The consolidated net loss widened to INR 280 crore in FY26, compared with INR 110 crore in FY25.

Management attributed the difficult year to persistent price pressure, excess global capacities, geopolitical disruptions, volatile feedstock and energy costs, and continued dumping of suspension PVC and paste PVC into India from China, Europe, and Japan. The quarter’s improvement came largely from better performance in specialty chemicals and a rebound in volumes, while the suspension PVC business continued to face severe spread volatility.

The Q4 rebound was led by specialty, but the revenue mix is still commodity-heavy

Chemplast Sanmar reports three major revenue buckets in its investor presentation: Specialty Chemicals, Value-added Chemicals, and Suspension PVC (through its wholly owned subsidiary, Chemplast Cuddalore Vinyls Limited).

In Q4 FY26, Specialty Chemicals revenue rose to INR 475 crore, Value-added Chemicals was INR 120 crore, and Suspension PVC revenue was INR 661 crore. On a full-year basis, Specialty Chemicals revenue increased to INR 1,537 crore, while Value-added Chemicals fell to INR 501 crore and Suspension PVC was INR 2,186 crore.

The company’s revenue mix continues to be led by suspension PVC. In FY26, the presentation indicates the split as 36 percent Specialty Chemicals, 12 percent Value-added Chemicals, and 52 percent Suspension PVC. For Q4 FY26, the split was 38 percent Specialty, 9 percent Value-added, and 53 percent Suspension PVC.

Specialty chemicals: Paste PVC stable, CMCD pipeline building, and R32 enters commercial production

The specialty segment carried the more constructive narrative in both the investor presentation and the earnings call.

Paste PVC: steady demand and regulatory optionality

Management said paste PVC demand remained steady during Q4, and the company continued to strengthen its market position. A key operational datapoint was that the Cuddalore paste PVC facility operated at 100 percent utilisation through the year.

A second important thread is regulation. The company stated it has received the final findings from DGTR in the antidumping duty investigation against imports from the European Union and Japan, and it is awaiting a notification by the Finance Ministry. In the concall, management stated that implementation of the ADD is expected during the first half of FY27.

CMCD: temporary agchem slowdown, but the pipeline remains a core asset

The Custom Manufactured Chemicals Division saw improved dispatches in Q4, though management said some volumes were deferred into the next quarter. The business remained impacted by the global agrochemical slowdown, which management characterized as temporary.

The company highlighted that the product pipeline continues to gain momentum, with 45 plus molecules progressing across various stages of development. In the concall, management clarified that the 45 molecules include 17 molecules that are commercial.

On capacity and execution, the investor presentation describes a phased expansion of the multi-purpose block. Phase 1 of the new MPB was commissioned in Sep 2023, Phase 2 in Dec 2024, and Phase 3 project activities are expected to be completed by Q1 FY27. The company also indicated that civil and infrastructure work for the next MPB is targeted for completion by Q2 FY27.

Refrigerant gases (R32): commercial production starts

Chemplast Sanmar announced that commercial production of R32 refrigerant gas at its 2 kt swing plant at Mettur commenced in May 2026. Management also said potential customers are being shortlisted with initial market engagement underway.

During the concall, management indicated that commissioning of new plants is expected to be undertaken in phases over the course of the year. They also stated a target of reaching 14 kt capacity by the end of calendar year 2026 and described a go-to-market strategy that includes both domestic sales and exports, with potential partnerships being explored for international markets.

Commodity pressure: suspension PVC volatility drives exceptional charges and impairment

The suspension PVC business was the center of the year’s most material setbacks.

Management explained that Q4 began positively, helped by dealer restocking and an expectation of improving prices. The Chinese government’s announcement to withdraw export rebates on PVC also supported price improvement early in the quarter.

But the Middle East conflict disrupted the market quickly. According to management, the war reduced availability of VCM in Asia due to acute shortages of naphtha and ethylene. VCM prices spiked sharply. PVC prices initially rose as well but did not sustain, because carbide-based PVC from China, which management said was largely immune to the war impact, began flooding India at very low prices. The result was a disconnect between PVC prices and feedstock costs.

The company also highlighted structural regulatory headwinds. It referred to the rescinding of QCOs and a recent reduction in customs duty that was only applicable till June 2026. Management indicated that regulatory support is critical for medium- to long-term stability, pointing to ADD and QCO as the most relevant levers.

Two notable accounting outcomes followed:

1. CCVL recorded an exceptional charge of INR 150 crore for the year ended March 31, 2026, towards provision for onerous contracts and write-down of raw materials. On the concall, the CFO stated this inventory write-down is expected to be reversed in the current financial year.

2. The parent company recorded a non-cash impairment loss of INR 898 crore on the carrying value of its investment in CCVL in standalone financials. Management described it as a reassessment under Ind AS 36, aligning book value with the current economic outlook. They emphasized it has no cash flow impact and does not affect consolidated financials.

Capital allocation and governance response: a strategic priorities review

A significant development in management commentary was the Board’s decision to constitute a committee of three independent directors to examine strategic priorities for the company with a view to enhance long-term value creation for stakeholders.

Management said the committee may evaluate potential reorganization and M and A opportunities and may engage advisors, before tabling its findings to the Board. In the concall, management described the mandate as a clean-state review of the portfolio, especially given the different outlook for specialty versus commodity businesses.

This step matters because Chemplast Sanmar is currently a combination of a specialty growth story and a commodity exposure that remains vulnerable to imports, feedstock disruptions, and regulatory outcomes. The committee signals a willingness to consider structural portfolio moves rather than relying only on cyclical recovery.

What to track in FY27

Chemplast Sanmar enters FY27 with two contrasting tracks.

On the positive side, the specialty chemicals narrative has clearer building blocks: paste PVC operating at full utilisation, a CMCD pipeline with 45 plus molecules and ongoing capacity additions, and the start of commercial R32 production with further capacity additions expected in phases.

On the risk side, the suspension PVC business faces a volatile near-term operating environment. Management described spreads as neutral on a replacement cost basis at the time of the concall, with continued uncertainty around Chinese imports, feedstock pricing, and the return of customs duty after June 2026. Regulatory support remains a key swing factor.

The company’s FY26 results show that a single quarter can improve quickly when spreads and volumes move in its favor, but also that structural risks in the commodity segments can overwhelm full-year profitability.

Cover image description: An ultra-realistic corporate desk scene showing a clean financial dashboard on a large monitor with three stacked area segments representing revenue mix for FY26: specialty chemicals 36 percent, value-added chemicals 12 percent, suspension PVC 52 percent. A separate small line chart shows consolidated EBITDA trend from FY22 to FY26 dipping sharply and stabilizing around 5 percent margin. The setting is neutral with soft office lighting and no logos or text labels.